ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America. The company offers NUPLAZID (pimavanserin), a selective serotonin in...
Leadership
Catherine E. Owen Adams
CEO & Director
Mark C. Schneyer
Executive VP & CFO
Jennifer J. Rhodes J.D.
Executive VP, Chief Legal Officer & Secretary
Elizabeth H. Z. Thompson Ph.D.
Executive VP and Head of Research & Development
Thomas Andrew Garner
Executive VP & Chief Commercial Officer
Scott Cenci
Senior VP, Chief Information & Data Officer
Albert S. Kildani
Senior Vice President of Investor Relations & Corporate Communications
